1. Background {#sec1-ijerph-14-01045}
=============

The term "polytrauma" has been frequently defined in terms of a high Injury Severity Score (ISS) and has been generally used interchangeably with terms such as "severely injured" or "multiple trauma" \[[@B1-ijerph-14-01045]\]. The internationally accepted threshold of an ISS ≥ 16 is based on the description as being predictive of a mortality risk above 10% \[[@B2-ijerph-14-01045]\]. However, a number of definitions of polytrauma with various ISS values (ISS \> 15 \[[@B3-ijerph-14-01045]\], ISS \> 16 \[[@B4-ijerph-14-01045]\], ISS \> 18 \[[@B5-ijerph-14-01045]\], ISS ≥ 18 \[[@B6-ijerph-14-01045]\], or ISS \> 25 \[[@B7-ijerph-14-01045]\]) have been reported in the literature. In addition, a high ISS may be attributed to a severe single-system injury (monotrauma) rather than "polytrauma," which refers to trauma patients whose injuries involve multiple body regions and in whom the combination of injuries would cause a life-threatening condition \[[@B8-ijerph-14-01045],[@B9-ijerph-14-01045]\]. If this concept is considered, polytrauma patients are expected to have a higher mortality rate than that obtained by the summation of expected mortality owing to their individual injuries \[[@B10-ijerph-14-01045]\], and to have more expensive therapeutic requirements \[[@B11-ijerph-14-01045]\], to require intensive resources for resuscitation, and to stay longer in the intensive care unit (ICU) \[[@B10-ijerph-14-01045]\].

Without a clear definition of polytrauma, any attempt to compare the loads, interventions, and outcomes of polytrauma patients among various trauma centers is challenging \[[@B10-ijerph-14-01045]\]. Some authors have suggested that at least two anatomical regions have to be injured for a patient to be identified as having polytrauma \[[@B9-ijerph-14-01045],[@B12-ijerph-14-01045],[@B13-ijerph-14-01045],[@B14-ijerph-14-01045]\]. The 'polytrauma' definition of Butcher and colleagues using the Abbreviated Injury Scale (AIS) ≥ 3 for at least two different body regions seemed more reasonable and feasible for identifying polytrauma patients \[[@B1-ijerph-14-01045],[@B10-ijerph-14-01045],[@B14-ijerph-14-01045]\]. With a higher mortality, more frequent ICU admissions, and longer hospital and ICU stays, this definition acts as a better predictor of morbidity and mortality than the definition using an ISS \> 15 or ISS \> 17 \[[@B1-ijerph-14-01045],[@B10-ijerph-14-01045],[@B14-ijerph-14-01045]\].

However, the definition of polytrauma based on the number of injured body regions does not reflect the physiological course after injury, which can be very dynamic in nature and may profoundly influence outcomes. Paffrath et al. even had reported that the mortality rate of polytrauma patients with an AIS ≥ 3 for at least two different body regions was even lower (18.7%) than that of patients with an ISS ≥ 16 (20.4%) \[[@B11-ijerph-14-01045]\]. Our unpublished study also revealed that under the definition of polytrauma by AIS ≥ 3 for at least two body regions, there was no significant difference in short-term mortality between polytrauma and non-polytrauma patients---i.e., polytrauma, as defined by AIS ≥ 3 for at least two body regions, was not a distinguishing factor for recognizing a significant difference in short-term mortality among trauma patients. To improve the specificity of the polytrauma definition, some additional qualifying criteria have been proposed, such as the requirement of laparotomy \[[@B15-ijerph-14-01045]\], existence of severe shock \[[@B16-ijerph-14-01045]\], involvement of at least one vital organ necessitating admission into the ICU \[[@B17-ijerph-14-01045]\], and systemic inflammatory response syndrome on at least one day during the first 72 h \[[@B10-ijerph-14-01045]\]. However, these additional criteria seemed to be limited and unverified. Moreover, the levels of variation and indication may differ among trauma centers.

The addition of a relevant physiologic condition or pathophysiologic change in combination of AIS/ISS is reasonable to increase its predictive power for mortality. Age, systolic blood pressure (SBP) and Glasgow Coma Scale (GCS) have been reported to have good predictive power for mortality \[[@B18-ijerph-14-01045]\]. An international consensus meeting in 2012 first tried to define polytrauma by combining the concept of injuries in different body regions and parameters of physiological response \[[@B19-ijerph-14-01045],[@B20-ijerph-14-01045]\]. With the addition of at least one of five standardized physiological responses (hypotension \[SBP ≤ 90 mmHg\], unconsciousness \[GCS score ≤ 8\], acidosis \[base excess ≤ −6.0\], coagulopathy \[partial thromboplastin time ≥ 40 s or international normalized ratio ≥ 1.4\], and age \[≥70 years\]) in this new "Berlin definition" to the definition of ISS ≥ 16 and AIS ≥ 3 for at least two body regions, an improved definition of polytrauma was determined \[[@B13-ijerph-14-01045]\]. Notably, in the study that defines polytrauma as AIS ≥ 3 points for two or more different body regions, mortality was 11.4% and 11.0% in polytrauma and non-polytrauma patients, respectively. A mortality rate of 18.7% was found when polytrauma was defined using ISS ≥ 16 \[[@B13-ijerph-14-01045]\] and the mortality rates were increased to as high as 35--38% as soon as one other physiologic parameter was added \[[@B13-ijerph-14-01045]\].

Before applying the definition of the polytrauma in the clinical setting, we designed this study to investigate the outcome of polytrauma patients, with polytrauma being defined by the new Berlin definition, who admitted and treated for all trauma injuries at a level I trauma center. The primary hypothesis of this study was that polytrauma patients have a worse outcome than patients with similar injury severity but without polytrauma. In this study---for the assessment of the effect of polytrauma on the outcomes---we compared the selected propensity score-matched groups of patients to minimize confounding effects due to non-randomized assignment of patients into the polytrauma or non-polytrauma groups.

2. Methods {#sec2-ijerph-14-01045}
==========

Study Design
------------

This study was approved by the Institutional Review Board (IRB) of Kaohsiung Chang Gung Memorial Hospital (reference number 201600544B0), a level I regional trauma center providing care to trauma patients primarily from southern Taiwan \[[@B21-ijerph-14-01045],[@B22-ijerph-14-01045]\]. Informed consent was waived according to IRB regulations. This retrospective study reviewed data of all hospitalized patients registered in the Trauma Registry System from 1 January 2009 to 31 December 2015. All patients with an overall ISS ≥ 18 who were admitted for treatment of traumatic injuries were included and allocated into a polytrauma group or non-polytrauma group. The choice of 18 as a threshold of ISS for non-polytrauma patients depends on the consideration that the polytrauma patients at least would have an ISS of 18 (3^2^ + 3^2^ = 18). The new Berlin definition of polytrauma was used and defined as follows \[[@B13-ijerph-14-01045]\]: a patient with AIS ≥ 3 for two or more different body regions with additional one or more variables from the five physiologic parameters, including SBP ≤ 90 mm Hg, GCS score ≤ 8, base excess ≤ 6.0, international normalized ratio ≥ 1.4 or partial thromboplastin time ≥ 40 s, and age ≥ 70 years.

The patients who had an overall ISS ≥ 18 but did not fit into the above criteria of polytrauma were defined as non-polytrauma patients. Patients with burn injury or incomplete registered data were excluded. Detailed patient information retrieved from the Trauma Registry System included the following: age; gender; trauma mechanism; initial GCS score in the emergency department (ED); vital signs assessed by the physician upon arrival at the ED and procedures performed by the physician at the ED (cardiopulmonary resuscitation, intubation, insertion of chest tube, and blood transfusion); co-morbidities, such as diabetes mellitus (DM), hypertension (HTN), coronary artery disease (CAD), congestive heart failure (CHF), cerebral vascular accident (CVA), and end-stage renal disease (ESRD); AIS severity score for each body region; ISS; rates of associated injuries; hospital length of stay (LOS); the rates of admission into the ICU as well as the LOS in ICU; in-hospital mortality; and total medical expenses, which included the cost of examination (physical examination, radiography examination, hematology testing, pathological examination, electrocardiography examination, endoscopy, echocardiogram, electromyography, cardiac catheterization, and electroencephalography monitoring), cost of operation (operation fee and operation supply fee), cost of pharmaceuticals (medical service, narcotics, and medicine), and other costs (fees for administrative tasks, registration, wards, nursing, blood/plasma tests, anesthesia, hemodialysis, rehabilitation, special material costs, and personal expenses), expressed as cost per victim in US dollars. The ISS is expressed as the median and interquartile range (IQR). Odds ratios (ORs) of the associated conditions and injuries of the patients were presented with 95% confidence intervals (CIs). The primary outcome of the study was in-hospital mortality, and the secondary outcomes were hospital LOS, ICU admission rate, ICU LOS, and the total medical expenses. The analysis was performed using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA). Two-sided Fisher exact or Pearson chi-square tests were used to compare categorical data. The unpaired Student *t*-test and Mann--Whitney *U*-test were used to analyze normally distributed continuous and non-normally distributed data, respectively, which was reported as mean ± standard deviation. To minimize confounding effects due to non-randomized assignment of patients into the polytrauma or non-polytrauma group, propensity score-matched groups of patients were selected for the assessment of the effect of polytrauma on the outcomes. A logistic regression model was used to calculate the propensity scores with the following covariates: gender; age, comorbidities, injury regions with AIS ≥ 3, and ISS. A 1:1 matched study group was created by the Greedy method with a 0.2 caliper width using NCSS 10 software (NCSS Statistical software, Kaysville, UT, USA). After adjustment of these confounding factors, binary logistic regression was used for evaluating the effect of polytrauma on the primary and secondary outcomes. *p*-values \< 0.05 were considered statistically significant.

3. Results {#sec3-ijerph-14-01045}
==========

3.1. Injury Characteristics and Severity of Polytrauma Patients {#sec3dot1-ijerph-14-01045}
---------------------------------------------------------------

After the exclusion of patients with an ISS less than 18 (*n* = 18,017), with a burn injury (*n* = 896), or incomplete registered data (*n* = 129) from 20,106 hospitalized patients, there were 369 and 1260 patients in the polytrauma and non-polytrauma group, respectively ([Figure 1](#ijerph-14-01045-f001){ref-type="fig"}). No significant differences in sex, age, pre-existing commodities, and injury mechanism were found between the polytrauma and non-polytrauma patients ([Table 1](#ijerph-14-01045-t001){ref-type="table"}). GCS scores were significantly lower for polytrauma patients than for non-polytrauma patients (9.2 ± 4.6 vs. 11.8 ± 4.2, respectively; *p* \< 0.001). Significantly more polytrauma patients had a GCS ≤ 8 than non-polytrauma patients. Analysis of injured body regions under the criteria of AIS ≥ 3, revealed that polytrauma patients had sustained significantly higher rates of face, thoracic, abdominal, and extremity injuries than non-polytrauma patients, while no difference in head and neck injury was found between polytrauma and non-polytrauma patients. The polytrauma patients had a significantly higher ISS than non-polytrauma patients (median (IQR: Q1--Q3), 29 (22--36) vs. 24 (20--25), respectively; *p* \< 0.001). In addition, more polytrauma patients had an ISS ≥ 25 and fewer patients had an ISS of 18--24 as compared to non-polytrauma patients.

3.2. Outcomes of Polytrauma Patients {#sec3dot2-ijerph-14-01045}
------------------------------------

Polytrauma patients had 1.9-fold higher odds of mortality than non-polytrauma patients (95% CI 1.38--2.49; *p* \< 0.001). Compared with non-polytrauma patients, polytrauma patients had significantly longer hospital LOS (20.0 days vs. 16.8 days, respectively; *p* \< 0.001) and longer LOS in the ICU (10.1 days vs. 8.3 days, respectively; *p* = 0.005). Moreover, compared to non-polytrauma patents, a higher proportion of polytrauma patients were admitted to the ICU (80.8% vs. 75.5%, respectively; *p* = 0.035). In addition, the polytrauma patients spent a significantly higher amount on medical expenses (41.8% higher), examinations (43.8% higher), operations (35.3% higher), and pharmaceuticals (58.2% higher) than non-polytrauma patients.

3.3. Associated Management and Injuries of Polytrauma Patients {#sec3dot3-ijerph-14-01045}
--------------------------------------------------------------

Polytrauma patients had significantly higher odds for worse hemodynamic measures and the requirement of procedures at the ED than non-polytrauma patients ([Table 2](#ijerph-14-01045-t002){ref-type="table"}). These measures included an SBP of \<90 mmHg, heart rate of \>100 beats/min, and respiratory rate of \<10 or \>29 times/min. The required procedures included cardiopulmonary resuscitation, intubation, insertion of chest tube, and blood transfusion. Polytrauma patients had significantly higher ORs for sustaining subarachnoid hemorrhage (OR 1.4, 95% CI 1.08--1.73; *p* = 0.010) but lower ORs for subdural hematomas (OR 0.7, 95% CI 0.57--0.91; *p* = 0.006) than non-polytrauma patients ([Table 3](#ijerph-14-01045-t003){ref-type="table"}). In addition, polytrauma patients had significantly higher ORs for sustaining trauma in the thoracic, abdominal, and extremity regions than non-polytrauma patients.

3.4. Adjusted Outcomes of Polytrauma Patients in Propensity Score--Matched Patient Population {#sec3dot4-ijerph-14-01045}
---------------------------------------------------------------------------------------------

A propensity score--matched patient population was selected to reduce the impact of demographic differences, pre-existing co-morbidities, and injury severity of the patient population on the outcome assessment between polytrauma and non-polytrauma patients ([Table 4](#ijerph-14-01045-t004){ref-type="table"}). In these 201 selected, well-balanced pairs of patients, there were no significant differences in sex, age, co-morbidity, number of patients with AIS ≥ 3, and ISS. The logistic regression analysis of these pairs of patients showed that polytrauma patients had significantly higher mortality (OR 17.5, 95% CI 4.21--72.76; *p* \< 0.001) than non-polytrauma patients. Compared with non-polytrauma patients, the polytrauma patients had a higher proportion of patients admitted to the ICU (84.1% vs. 74.1%, respectively; *p* = 0.013) and a longer stay in ICU (10.3 days vs. 7.5 days, respectively; *p* = 0.003), but there was no significant difference in the hospital LOS (21.1 days vs. 19.8 days, respectively; *p* = 0.399). In addition, polytrauma patients still had a significantly higher total medical expense (35.1% higher), cost of examination (33.1% higher), cost of operation (40.6% higher), and cost of pharmaceuticals (53.9% higher) than the non-polytrauma patients.

4. Discussion {#sec4-ijerph-14-01045}
=============

This study compared clinical outcomes in a broad group of hospitalized polytrauma and non-polytrauma patients to investigate the feasibility and applicability of the new Berlin definition of polytrauma. We found that polytrauma patients presented with significantly higher morbidity and mortality than non-polytrauma patients. More importantly, even after consideration of the differences in demographic characteristics, co-morbidities, and injury severity of the trauma patient population, the selected propensity score--matched polytrauma patients still had a significantly higher proportion of patients admitted to the ICU with a longer stay, a higher total medical cost, and higher mortality than non-polytrauma patients.

Polytrauma is generally used to describe trauma patients whose injuries involve multiple body regions, compromise the patient's physiology and potentially cause dysfunction of uninjured organs \[[@B13-ijerph-14-01045]\]. The expected higher risk of mortality of polytrauma patients is based on the assumption that the underlying pathophysiological response of the injured person would aggravate the clinical outcome. The injured person's pathophysiological response to the injury load, however, makes a differentiation between "polytrauma" and "multitrauma" \[[@B10-ijerph-14-01045]\]. For example, many reports had indicated that head and brain injuries and thoracic traumata are major risk factors in trauma patients and that co-occurrence of these factors leads to an exponential increase in mortality \[[@B23-ijerph-14-01045],[@B24-ijerph-14-01045],[@B25-ijerph-14-01045]\]. The reduced pulmonary reserves in lung contusion may rapidly lead to hypoventilation and hypoxia that cause secondary injury to the brain or pose more burden to other organ systems. Early intubation was also a significant risk factor for cerebral impairment in patients with multiple trauma \[[@B26-ijerph-14-01045]\]. The injury to the gastrointestinal system may interfere with the nutrition balance and increase bacterial translocation \[[@B27-ijerph-14-01045],[@B28-ijerph-14-01045]\]---moreover, increasing levels of endotoxemia following polytrauma have been reported \[[@B29-ijerph-14-01045]\]. Likewise, hypovolemic shock and massive blood transfusion are often associated with coagulopathy and imbalance in acid-base homeostasis \[[@B30-ijerph-14-01045]\]. Notably, in this study polytrauma patients had statistically significant higher ORs for sustaining thoracic trauma and abdominal trauma as well as for requiring procedures including cardiopulmonary resuscitation, intubation, chest tube insertion, and blood transfusion at the ED. These combined scenarios may explain partly, but not enough, our observation of a higher mortality in the selected propensity score--matched polytrauma patients than that in non-polytrauma patients.

A combination of injury severity, relevant pathophysiologic change, or physiologic changes seemed be useful for mortality prediction \[[@B13-ijerph-14-01045]\]. The dysregulation of the immune system after trauma presents one of the greatest threats to life \[[@B31-ijerph-14-01045],[@B32-ijerph-14-01045]\]. However, a formally defined pathophysiological response to trauma remains a challenge. In addition, even in a prospective study, the practicability of including systemic inflammatory response syndrome into the definition of polytrauma as a surrogate for physiological derangement was questioned \[[@B33-ijerph-14-01045]\]. In contrast, the selected five physiological parameters (hypotension \[SBP ≤ 90 mmHg\], unconsciousness \[GCS score ≤ 8\], acidosis \[base excess ≤ −6.0\], coagulopathy \[partial thromboplastin time ≥ 40 s or international normalized ratio ≥ 1.4\], and age \[≥70 years\]) of the new "Berlin definition" for polytrauma are deemed feasible worldwide and easily approachable with less ambiguity \[[@B13-ijerph-14-01045]\]. This study based on a propensity-score matching approach may provide more evidence to support the use of such a definition of polytrauma in clinical settings to manage with polytrauma patients.

In this study, the non-polytrauma group is composed of two different types of patients: first, patients with only one body region affected (AIS ≥ 4), with or without physiological problems; and second, patients with two or more body regions affected, but no physiological problem. The matching used in this study is prone to select the latter group of patients for comparison, thus may have a selection bias. This study has some other limitations that should be acknowledged. First, the retrospective design of the study would carry an inherent selection bias. Second, the patients declared dead at the accident scene or on hospital arrival were not included in the Trauma Registry Database, which may have led to a selection bias. Third, as the registered data lacked uniform indication of hospitalization and admission into ICU, as well as the type of surgery performed on patients, we could only rely on the assumption that management of patients with or without polytrauma was uniform. Further, long-term mortality was not evaluated in this study. Finally, the physiological problems also work in isolated trauma \[[@B11-ijerph-14-01045]\]. With an increasing number of physiological factors there was an almost linear increase in mortality up to an 86% rate in patients with all five physiological factors present \[[@B11-ijerph-14-01045]\]. In this study, the addition of physiological factor(s) to the polytrauma but not to non-polytrauma patients, making the present non-polytrauma group is a mixture of two groups with separate injury pattern, i.e. one with, and one without, a physiological problem. Therefore, a selection bias may be existed in the comparison.

5. Conclusions {#sec5-ijerph-14-01045}
==============

As we noted a significantly higher incidence of morbidity and mortality in polytrauma patients than in non-polytrauma patients, our study findings based on propensity-score matching validate the new definition of polytrauma based on the new Berlin definition, as a case with AIS ≥ 3 for two or more different body regions with additional one or more variables from the five physiologic parameters.

Cheng-Shyuan Rau wrote the manuscript, Shao-Chun Wu was involved in the review of literature, Pao-Jen Kuo was responsible for the integrity of registered data, Yi-Chun Chen performed the statistical analyses, Hsiao-Yun Hsieh proofread the manuscript, and Ching-Hua Hsieh designed the study and contributed to the analysis and interpretation of data. All authors read and approved the final manuscript.

The authors declare that they have no competing interests.

![Flow chart of the studied polytrauma and non-polytrauma population.](ijerph-14-01045-g001){#ijerph-14-01045-f001}

ijerph-14-01045-t001_Table 1

###### 

Demographics and injury characteristics of polytrauma and non-polytrauma patients.

  Variables                 Polytrauma *n* = 369   Non-Polytrauma *n* = 1260   *Odds Ratio (95% CI)*   *p*
  ------------------------- ---------------------- --------------------------- ----------------------- ---------
  Sex                                                                                                  0.610
  Male                      255 (69.1)             853 (67.7)                  1.1 (0.83--1.37)        
  Female                    114 (30.9)             407 (32.3)                  0.9 (0.73--1.20)        
  Age                       49.9 ± 22.9            47.3 ± 19.9                 ---                     0.052
  Comorbidity                                                                                          
  DM                        37 (10.0)              169 (13.4)                  0.7 (0.49--1.05)        0.085
  HTN                       79 (21.4)              275 (21.8)                  1.0 (0.74--1.29)        0.865
  CAD                       15 (4.1)               36 (2.9)                    1.4 (0.78--2.66)        0.241
  CHF                       1 (0.3)                3 (0.2)                     1.1 (0.12--10.98)       1.000
  CVA                       5 (1.4)                30 (2.4)                    0.6 (0.22--1.46)        0.232
  ESRD                      0 (0.0)                1 (0.1)                     ---                     1.000
  Mechanism, n (%)                                                                                     
  MV Driver                 19 (5.1)               39 (3.1)                    1.7 (0.97--2.98)        0.061
  MV Passenger              11 (3.0)               19 (1.5)                    2.0 (0.95--4.26)        0.064
  Motorcycle Driver         222 (60.2)             792 (62.9)                  0.9 (0.70--1.13)        0.348
  Motorcycle Pillion        18 (4.9)               38 (3.0)                    1.6 (0.93--2.93)        0.084
  Bicycle                   10 (2.7)               53 (4.2)                    0.6 (0.32--1.26)        0.190
  Pedestrian                20 (5.4)               48 (3.8)                    1.4 (0.85--2.47)        0.174
  Fall                      59 (16.0)              230 (18.3)                  0.9 (0.62--1.17)        0.317
  Penetrating injury        1 (0.3)                2 (0.2)                     1.7 (0.16--18.90)       0.537
  Struck by/against         9 (2.4)                39 (3.1)                    0.8 (0.38--1.63)        0.512
  GCS                       9.2 ± 4.6              11.8 ± 4.2                  ---                     \<0.001
  ≤8                        200 (54.2)             301 (23.9)                  3.8 (2.96--4.80)        \<0.001
  9-12                      32 (8.7)               181 (14.4)                  0.6 (0.38--0.84)        0.004
  ≥13                       137 (37.1)             778 (61.7)                  0.4 (0.29--0.47)        \<0.001
  AIS ≥ 3, n (%)                                                                                       
  Head/Neck                 281 (76.2)             940 (74.6)                  1.1 (0.83--1.43)        0.546
  Face                      19 (5.1)               12 (1.0)                    5.6 (2.71--11.74)       \<0.001
  Thorax                    237 (64.2)             378 (30.0)                  4.2 (3.28--5.35)        \<0.001
  Abdomen                   82 (22.2)              136 (10.8)                  2.4 (1.74--3.20)        \<0.001
  Extremity                 183 (49.6)             191 (15.2)                  5.5 (4.26--7.11)        \<0.001
  ISS, median (IQR)         29 (22--36)            24 (20--25)                 ---                     \<0.001
  18--24                    100 (27.1)             727 (57.7)                  0.3 (0.21--0.35)        \<0.001
  ≥25                       269 (72.9)             533 (42.3)                  3.7 (2.84--4.74)        \<0.001
  Mortality, n (%)          80 (21.7)              164 (13.0)                  1.9 (1.38--2.49)        \<0.001
  Hospital LOS (days)       20.0 ± 16.8            16.8 ± 15.6                 ---                     0.001
  ICU                                                                                                  
  Patients, n (%)           298 (80.8)             951 (75.5)                  1.4 (1.02--1.82)        0.035
  18--24                    66 (22.1)              479 (50.4)                  0.3 (0.21--0.38)        \<0.001
  ≥25                       232 (77.9)             472 (49.6)                  3.6 (2.64--4.82)        \<0.001
  LOS in ICU (days)         10.1 ± 9.5             8.3 ± 9.5                   ---                     0.005
  Medical expenses          8888 ± 8141            6270 ± 6915                 ---                     \<0.001
  Cost of examination       591 ± 536              411 ± 493                   ---                     \<0.001
  Cost of operation         1103 ± 1198            815 ± 1084                  ---                     \<0.001
  Cost of pharmaceuticals   791 ± 1291             500 ± 1028                  ---                     \<0.001

AIS = abbreviated injury scale; CAD = coronary artery disease; CHF = Congestive Heart Failure; CI = confidence interval; CVA = cerebral vascular accident; DM = diabetes mellitus; ESRD = end-stage renal disease; GCS = Glasgow Coma Scale; HTN = hypertension; ICU = intensive care unit; IQR = interquartile range; ISS = injury severity score; LOS = length of stay; MV = motor vehicle.
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###### 

Physiological response and procedures performed upon arrival at the emergency department for polytrauma and non-polytrauma patients.

  Variables                       Polytrauma *n* = 369   Non-Polytrauma *n* = 1260   *Odds Ratio (95% CI)*   *p*
  ------------------------------- ---------------------- --------------------------- ----------------------- ---------
  Physiology at ED, n (%)                                                                                    
  SBP \< 90 mmHg                  80 (21.7)              50 (4.0)                    6.7 (4.60--9.76)        \<0.001
  HR \> 100 beats/min             154 (41.7)             358 (28.4)                  1.8 (1.42--2.30)        \<0.001
  RR \< 10 or \> 29 times/min     36 (9.8)               29 (2.3)                    4.6 (2.77--7.60)        \<0.001
  Procedures at ED, n (%)                                                                                    
  Cardiopulmonary resuscitation   15 (4.1)               11 (0.9)                    4.8 (2.19--10.57)       \<0.001
  Intubation                      90 (24.4)              187 (14.8)                  1.9 (1.39--2.46)        \<0.001
  Chest tube insertion            59 (16.0)              84 (6.7)                    2.7 (1.87--3.80)        \<0.001
  Blood transfusion               145 (39.3)             132 (10.5)                  5.5 (4.20--7.29)        \<0.001

ED = emergency department; HR = heart rate; RR = respiratory rate; SBP = systolic blood pressure.

ijerph-14-01045-t003_Table 3

###### 

Significant associated injuries in polytrauma and non-polytrauma patients.

  Variables                       Polytrauma *n* = 369   Non-Polytrauma *n* = 1260   *Odds Ratio (95% CI)*   *p*
  ------------------------------- ---------------------- --------------------------- ----------------------- ---------
  Head trauma, n (%)                                                                                         
  Neurologic deficit              14 (3.8)               33 (2.6)                    1.5 (0.78--2.77)        0.236
  Cranial fracture                100 (27.1)             349 (27.7)                  1.0 (0.75--1.26)        0.821
  Epidural hematoma (EDH)         74 (20.1)              310 (24.6)                  0.8 (0.58--1.02)        0.070
  Subdural hematoma (SDH)         155 (42.0)             631 (50.1)                  0.7 (0.57--0.91)        0.006
  Subarachnoid hemorrhage (SAH)   157 (42.5)             443 (35.2)                  1.4 (1.08--1.73)        0.010
  Intracerebral hematoma (ICH)    46 (12.5)              129 (10.2)                  1.2 (0.87--1.79)        0.224
  Cerebral contusion              71 (19.2)              261 (20.7)                  0.9 (0.68--1.22)        0.537
  Maxillofacial trauma, n (%)                                                                                
  Orbital fracture                10 (2.7)               55 (4.4)                    0.6 (0.31--1.21)        0.153
  Maxillary fracture              53 (14.4)              195 (15.5)                  0.9 (0.66--1.27)        0.601
  Mandibular fracture             15 (4.1)               48 (3.8)                    1.1 (0.59--1.93)        0.823
  Thoracic trauma, n (%)                                                                                     
  Rib fracture                    141 (38.2)             337 (26.7)                  1.7 (1.33--2.16)        \<0.001
  Hemothorax                      59 (16.0)              89 (7.1)                    2.5 (1.76--3.56)        \<0.001
  Pneumothorax                    50 (13.6)              107 (8.5)                   1.7 (1.18--2.42)        0.004
  Hemopneumothorax                53 (14.4)              92 (7.3)                    2.1 (1.49--3.05)        \<0.001
  Lung contusion                  48 (13.0)              72 (5.7)                    2.5 (1.68--3.63)        \<0.001
  Abdominal trauma, n (%)                                                                                    
  Hepatic injury                  57 (15.4)              103 (8.2)                   2.1 (1.45--2.90)        \<0.001
  Splenic injury                  46 (12.5)              47 (3.7)                    3.7 (2.40--5.62)        \<0.001
  Retroperitoneal injury          9 (2.4)                8 (0.6)                     3.9 (1.50--10.21)       0.006
  Renal injury                    13 (3.5)               25 (2.0)                    1.8 (0.91--3.56)        0.085
  Extremity trauma, n (%)                                                                                    
  Clavicle fracture               54 (14.6)              224 (17.8)                  0.8 (0.57--1.10)        0.158
  Humeral fracture                26 (7.0)               54 (4.3)                    1.7 (1.04--2.74)        0.031
  Radial fracture                 38 (10.3)              78 (6.2)                    1.7 (1.16--2.61)        0.007
  Ulnar fracture                  22 (6.0)               54 (4.3)                    1.4 (0.85--2.36)        0.179
  Pelvic fracture                 43 (11.7)              82 (6.5)                    1.9 (1.28--2.80)        0.001
  Femoral fracture                99 (26.8)              86 (6.8)                    5.0 (3.64--6.88)        \<0.001
  Patella fracture                15 (4.1)               18 (1.4)                    2.9 (1.46--5.86)        0.002
  Tibia fracture                  58 (15.7)              59 (4.7)                    3.8 (2.59--5.57)        \<0.001
  Fibular fracture                43 (11.7)              44 (3.5)                    3.6 (2.35--5.65)        \<0.001
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###### 

Covariates and the assessment of outcomes in polytrauma and non-polytrauma patients adjusted in 1:1 Greedy propensity-score matching.

  Variables                Polytrauma *n* = 201   Non-Polytrauma *n* = 201   *Odds Ratio (95%)*   *p*
  ------------------------ ---------------------- -------------------------- -------------------- ---------
  Sex                                                                                             1.000
  Male                     149 (74.1)             149 (74.1)                 1.0 (0.64--1.56)     
  Female                   52 (25.9)              52 (25.9)                  1.0 (0.64--1.56)     
  Age                      43.2 ± 20.0            43.4 ± 16.4                ---                  0.919
  Comorbidity                                                                                     
  DM                       12 (6.0)               12 (6.0)                   1.0 (0.44--2.28)     1.000
  HTN                      27 (13.4)              27 (13.4)                  1.0 (0.56--1.77)     1.000
  CAD                      0 (0.0)                0 (0.0)                    ---                  ---
  CHF                      0 (0.0)                0 (0.0)                    ---                  ---
  CVA                      0 (0.0)                0 (0.0)                    ---                  ---
  ESRD                     0 (0.0)                0 (0.0)                    ---                  ---
  AIS ≥ 3, *n* (%)                                                                                
  Head/Neck                144 (71.6)             144 (71.6)                 1.0 (0.65--1.54)     1.000
  Face                     5 (2.5)                5 (2.5)                    1.0 (0.29--3.51)     1.000
  Thorax                   133 (66.2)             133 (66.2)                 1.0 (0.66--1.51)     1.000
  Abdomen                  45 (22.4)              45 (22.4)                  1.0 (0.63--1.60)     1.000
  Extremity                99 (49.3)              99 (49.3)                  1.0 (0.68--1.48)     1.000
  ISS, median (IQR)        27 (22--34)            26 (22--29)                ---                  0.271
  Mortality, n (%)         35 (17.4)              2 (1.0)                    17.5 (4.21--72.76)   \<0.001
  Hospital LOS (days)      21.1 ± 16.2            19.8 ± 14.4                ---                  0.399
  ICU                                                                                             
  Patients, n (%)          169 (84.1)             149 (74.1)                 2.0 (1.15--3.30)     0.013
  LOS in ICU (days)        10.3 ± 9.3             7.5 ± 7.4                  ---                  0.003
  Medical expenses         9634 ± 8850            7129 ± 6800                ---                  0.002
  Cost of examination      627 ± 584              471 ± 516                  ---                  0.005
  Cost of operation        1225 ± 1238            871 ± 1039                 ---                  0.002
  Cost of pharmaceutical   851 ± 1431             553 ± 1085                 ---                  0.019

AIS = abbreviated injury scale; CAD = coronary artery disease; CHF = Congestive Heart Failure; CI = confidence interval; CVA = cerebral vascular accident; DM = diabetes mellitus; ESRD = end-stage renal disease; HTN = hypertension; ICU = intensive care unit; IQR = interquartile range; ISS = injury severity score; LOS = length of stay.
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